Lilium International Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 209.15%
- Profit Growth 186.10%
- Ebitda 123.03%
- Net Worth 358.86%
- Total Assets 28.33%
About Lilium International
Lilium International Private Limited (LIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 December 2012 and has a history of 12 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sujay Singh and Pramod Singh serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U36101MH2012PTC238751
-
Company No.
238751
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Dec 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Lilium International?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujay Singh
|
Director | 22-Jun-2020 | Current |
|
Pramod Singh
|
Director | 13-Dec-2012 | Current |
Financial Performance of Lilium International.
Lilium International Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 209.15% increase. The company also saw a substantial improvement in profitability, with a 186.1% increase in profit. The company's net worth Soared by an impressive increase of 358.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lilium International?
In 2022, Lilium International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sanatio Pharmaceuticals Private LimitedPramod Singh is a mutual person
-
Windlock Project Private LimitedSujay Singh is a mutual person
-
Conta Healthcare Private Limited
Pramod Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lilium International?
Unlock and access historical data on people associated with Lilium International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lilium International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lilium International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
